(19)

(11)

EP 4 816 004 A1

(12)

(43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24895230.1 (22) Date of filing: 29.11.2024

(51) International Patent Classification (IPC):  A61K 51/10(2006.01) A61K 39/395(2006.01) A61P 35/00(2006.01) C07K 16/40(2006.01) A61K 39/00(2006.01) A61P 13/10(2006.01) C07K 16/30(2006.01) (52) Cooperative Patent Classification (CPC): C07K 16/30; A61K 2039/54; A61K 2039/545; A61K 2039/505; A61P 35/00; A61K 51/1096; A61K 51/1027; A61K 51/106; A61K 51/1075; C07K 2317/24; C07K 2317/77 (86) International application number: PCT/AU2024/051284 (87) International publication number: WO 2025/111661 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.12.2023 AU 2023903890 (71) Applicants: Telix Pharmaceuticals (Innovations) Pty Ltd North Melbourne, Victoria 3051 (AU) Atonco SAS 44800 Saint-Herblain (FR)

(72) Inventors: WHEATCROFT, Michael North Melbourne, Victoria 3051 (AU) CHATAL, Jean-François 44380 Pornichet (FR) (74) Representative: Lawrie IP Limited  10 Bothwell Street Glasgow G2 6LU Glasgow G2 6LU (GB)